FDA Clears Novalung For Treatment Of Acute Respiratory And Cardiopulmonary Failure

Fresenius Medical Care North America Announces First Extracorporeal Membrane Oxygenation (ECMO) System Cleared For Long-Term UseFresenius Medical Care North America (FMCNA) today announced that the U.S. Food and Drug Administration (FDA) has cleared Novalung®, a heart and lung support system for the treatment of acute respiratory or cardiopulmonary failure. Novalung is the first extracorporeal membrane oxygenation (ECMO) system […]